Good morning :)
Place Order
Add to Watchlist

Dipna Pharmachem Ltd

DPL

Dipna Pharmachem Ltd

DPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹31 cr, stock is ranked 3,815
High RiskStock is 4.60x as volatile as Nifty
13.264.99% (+0.63)
13.264.99% (+0.63)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹31 cr, stock is ranked 3,815
High RiskStock is 4.60x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹31 cr, stock is ranked 3,815
High RiskStock is 4.60x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
0.85
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.256.020.55%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dipna Pharmachem Limited trades and imports pharmaceutical raw materials and active ingredients, assisting in contract manufacturing compliance.

PE Ratio
40.32
1Y Return
0.22%
Buy Reco %
85.29
PE Ratio
28.58
1Y Return
1.67%
Buy Reco %
72.73
PE Ratio
62.81
1Y Return
15.35%
Buy Reco %
68.00
PE Ratio
49.95
1Y Return
7.51%
Buy Reco %
80.00
PE Ratio
16.93
1Y Return
10.40%
Buy Reco %
45.16
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 52.1%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.01% to 0.04%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 93.32%, vs industry avg of 15.27%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue16.5720.1930.5531.0272.7799.94164.34
Raw Materialssubtract17.0817.5231.1631.2267.67108.13176.35
Power & Fuel Costsubtract0.010.010.000.000.000.000.01
Employee Costsubtract0.000.000.380.410.000.000.00
Selling & Administrative Expensessubtract0.700.630.610.541.661.922.77
Operating & Other expensessubtract-1.621.53-2.07-1.571.25-12.48-18.24
Depreciation/Amortizationsubtract0.000.010.010.010.010.010.02
Interest & Other Itemssubtract0.330.430.390.350.610.972.01
Taxes & Other Itemssubtract0.010.020.000.030.410.470.34
EPS2.931.963.421.4756.741.250.56
DPS0.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dipna Pharmachem Ltd29.520.85
Sun Pharmaceutical Industries Ltd40.325.750.84%
Cipla Ltd28.584.390.89%
Torrent Pharmaceuticals Ltd62.8115.170.91%

Price Comparison

Compare DPL with any stock or ETF
Compare DPL with any stock or ETF
DPL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding9.98%0.00%0.00%0.00%90.02%

Sep 2023

Dec 2023

Mar 2024

Sep 2024

Shareholding History

SepMarSepDec '23MarSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

DPL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Dipna Pharmachem to hold board meeting

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 12 March 2025.Powered by Capital Market - Live

1 hour agoCapital Market - Live
Corporate
Dipna Pharmachem announces board meeting date

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 24 February 2025.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Dipna Pharmachem to convene board meeting

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Dipna Pharmachem announces board meeting date

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Dipna Pharmachem Ltd (DPL) today?

    The share price of DPL as on 7th March 2025 is ₹13.26. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Dipna Pharmachem Ltd (DPL) share?

    The past returns of Dipna Pharmachem Ltd (DPL) share are
    • Past 1 week: -2.85%
    • Past 1 month: -22.52%
    • Past 3 months: 64.52%
    • Past 6 months: 62.10%
    • Past 1 year: 15.30%
    • Past 3 years: N/A%
    • Past 5 years: -51.68%

  3. What are the peers or stocks similar to Dipna Pharmachem Ltd (DPL)?
  4. What is the market cap of Dipna Pharmachem Ltd (DPL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dipna Pharmachem Ltd (DPL) is ₹31.88 Cr as of 7th March 2025.

  5. What is the 52 week high and low of Dipna Pharmachem Ltd (DPL) share?

    The 52-week high of Dipna Pharmachem Ltd (DPL) is ₹16.55 and the 52-week low is ₹6.40.

  6. What is the PE and PB ratio of Dipna Pharmachem Ltd (DPL) stock?

    The P/E (price-to-earnings) ratio of Dipna Pharmachem Ltd (DPL) is 29.52. The P/B (price-to-book) ratio is 0.85.

  7. Which sector does Dipna Pharmachem Ltd (DPL) belong to?

    Dipna Pharmachem Ltd (DPL) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Dipna Pharmachem Ltd (DPL) shares?

    You can directly buy Dipna Pharmachem Ltd (DPL) shares on Tickertape. Simply sign up, connect your demat account and place your order.